Which vaccines were studied?
Tdap vaccine: a combination vaccine that Placebo: a saline water solution.
is used to protect against three infectious
diseases: diphtheria, tetanus and
whooping cough.
How was the study done?
The pregnant women were placed in 2 study Blood samples were taken before and after the
groups: injection of the vaccine or placebo during
pregnancy. Blood from the umbilical cord (called
Tdap group: In this group, women got the
“cord blood”) was collected after birth. The
Tdap vaccine during pregnancy and a
blood samples were then tested to compare the
placebo soon after delivery.
amounts of antibodies in the 2 groups.
Placebo group: In this group, women got
The study took about 5 months for each mother.
the placebo during pregnancy and a Tdap
vaccine soon after delivery.
Figure 1. Study design - Overview of time and events
What were the main results of the study?
This report focuses only on the results of the main goals of the study. All results may be found in the clinical
results summary.
The main goal of the study was to look at the amounts of antibodies that were transferred from the
mothers to their babies through the umbilical cord. The results are presented in Figure 2.
Measuring antibody levels against whooping cough, diphtheria and tetanus in pregnant women were
additional goals of the study. The results are presented in Figure 3 and Figure 4.